Abstract: Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.

Abstract: Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided.

Abstract: The present disclosure discloses a composition for skin anti-inflammation and skin moisturizing, which contains an Artemisia extract extracted using a skin cosmetic solution as an extraction solvent as an active ingredient. Specifically, the composition according to the present disclosure, which contains the Artemisia extract obtained using an effective and safe extraction solvent, may exhibit superior kin safety and usability as well as superior anti-inflammatory and moisturizing effects. In addition, the composition according to the present disclosure, which contains the Artemisia extract extracted using the skin cosmetic solution that can be used as a cosmetic ingredient as an extraction solvent, may superbly maintain Artemisia flavor without an additional flavoring agent.

Abstract: A cosmetic composition containing a mixture of Brassica oleracea var. acephala seawater extract, Nasturtium officinale seawater extract and Beta vulgaris Root seawater extract is disclosed. The cosmetic composition enhances the barrier function of the skin, improves skin moisturizing ability and promotes cell turnover. A use of the composition for improving skin condition and for the manufacture of cosmetics, which function to enhance the barrier function of the skin, improve skin moisturizing ability, and promote skin cell turnover is disclosed.

Abstract: Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.

Abstract: Provided are a wireless power transmission device and a wireless power transmission system. The wireless power transmission device, according to one embodiment of the present invention, may comprise: a dipole coil comprising a core, and a conducting wire wound at the center part of the core; a power unit for supplying a current to the conducting wire; and a canceling coil for canceling a magnetic field radiated from a lateral surface of the dipole coil.

Abstract: The present invention relates to a skin external composition containing an extract of green tea produced by an extreme light-shielding cultivation method, which is distinguished from a conventional light-shielding cultivation method of green tea. More specifically, the present invention relates to a skin external composition, which contains an extract of green tea cultivated by extreme light-shielding, in which the amino acid content is remarkably increased by cultivating the green tea by a light-shielding cultivation under a light-shielding rate of 99% or more, thereby obtaining more excellent skin moisturizing, skin protecting, and anti-aging effects.

Abstract: The present specification relates to a method for extracting a plant by using a skin serum that can be used for skin care. This method can further increase the process efficiency and extract active ingredients more effectively than conventional extraction methods using a solvent. Thus, the method can increase customer satisfaction and promote the development of relevant industries.

Abstract: A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.

Abstract: A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.

Abstract: An adhesive matrix and adhesive formulation are described. The adhesive matrix is comprised of a hydrophilic domain and a hydrophobic domain, and a therapeutically active agent contained in the matrix in a supersaturated, stable, condition. The hydrophilic domain and the hydrophobic domain are co-soluble in a solvent system, to provide a homogeneous blend in which the active agent is solubilized. The proportion of the hydrophilic domain and hydrophobic domain is selected to optimize, or maximize, solubility of active agent in the matrix.

Abstract: Provided are a wireless power transmission device and a wireless power transmission system. The wireless power transmission device, according to one embodiment of the present invention, may comprise: a dipole coil comprising a core, and a conducting wire wound at the center part of the core; a power unit for supplying a current to the conducting wire; and a canceling coil for canceling a magnetic field radiated from a lateral surface of the dipole coil.

Abstract: The present invention relates to a display apparatus and operational method therefor, and an electronic apparatus, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a capacitance variance unit for varying the capacitance (Cv) of the resonance circuit unit in order to control the resonance point thereof, the resonance point having been changed due to the distance from the external apparatus; and a display panel for implementing an image by means of the voltage.

Abstract: Methods, compositions, and devices for transdermally administering an active agent such as memantine are provided.

Abstract: Methods, compositions, and devices for transdermally administering an active agent such as donepezil are provided. In one aspect, the method comprises contacting skin with a transdermal device designed to create a depot of the active agent in the subject, removing the transdermal device and continuing to administer the active agent for a period after the device is removed.

Abstract: A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.

Abstract: A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.

Abstract: The present invention relates to an electronic apparatus and display apparatus, and method for driving the apparatuses, and the display apparatus according to an embodiment of the present invention may comprise: a resonance circuit unit for generating voltage by means of inductive electromotive force generated due to an external apparatus; a rectification unit for rectifying the output voltage of the resonance circuit unit; and a converter for outputting the rectified voltage of the rectification unit as the target voltage by varying duty on the basis of duty data and target voltage determined in accordance with the distance from the external apparatus.

Abstract: In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier.

Abstract: A transdermal delivery system is described, where the system comprises a drug reservoir layer comprising an active agent and a skin contact adhesive layer. A microporous membrane that has been pretreated with a membrane treatment composition before the membrane is incorporated into the system is disposed between the drug reservoir layer and the skin contact adhesive layer.